Redeye has revised its estimates for Modelon following the Q1 2024 report and the announced rights i...
Redeye updates its estimates of Ependion and discusses both the most recent report and Beijer Electr...
Redeye comments on Lipigon's Q1 report 2024. Since our last update, patient recruitment to the phase...
Cibus acquires six grocery-anchored assets in Sweden for SEK 87.
NOSIUM har publicerat bolagets delårsrapport för det första kvartalet 2024.
The bid is supported by 44.6% of shareholders, representing a bid premium of 74% compared with yeste...
VIMAB Group är en industrikoncern verksamt inom miljö, elektrifiering och near-shoring.
Redeye comments on the readout from the phase IIa study of naptumomab in combination with docetaxel ...
Systemair möter ytterligare ett kvartal med tuffa jämförelser när de rapporterar det fjärde kvartale...
Redeye comments on Enviro’s Q1 report, which presented no real surprises.
Redeye provides a research update following the Q1 report published by Alzinova earlier today.
Patientrekryteringen i mål I kvartalet inkluderades den sista patienten till bolagets pågående fas 1...
Redeye initiates coverage of AcouSort, a Swedish medtech company aiming to introduce its unique acou...
On the 23rd of May, ChromoGenics largest owner, Färna Invest, placed a takeover bid of SEK10 for the...
JV with French group Eiffage to build Copenhagen rainfall tunnel MTH DK's share is just over 50% Gui...
Q1e: one Freemelt ONE delivery, SEK 4.9m sales, SEK -8.
Redeye provides a preview for Integrum’s Q4 report, due on Thursday, May 30.
Redeye gives its initial comment on the news that Kristina Torfgård has been appointed CEO of IRLAB.
Efter några år av trevande försäljning på selekterade marknader i EU riktar Prostatype Genomics nu f...
I dag offentliggjorde edyoutec sin delårsrapport för kv1 2024.
